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Abstract
Rare cancers together constitute one fourth of cancers. As some rare cancers are caused by occupational exposures, a system-
atic search for further associations might contribute to future prevention. We undertook a European, multi-center case–control 
study of occupational risks for cancers of small intestine, bone sarcoma, uveal melanoma, mycosis fungoides, thymus, male 
biliary tract and breast. Incident cases aged 35–69 years and sex-and age-matched population/colon cancer controls were 
interviewed, including a complete list of jobs. Associations between occupational exposure and cancer were assessed with 
unconditional logistic regression controlled for sex, age, country, and known confounders, and reported as odds ratios (OR) 
with 95% confidence intervals (CI). Interviewed were 1053 cases, 2062 population, and 1084 colon cancer controls. Male 
biliary tract cancer was associated with exposure to oils with polychlorinated biphenyls; OR 2.8 (95% CI 1.3–5.9); male 
breast cancer with exposure to trichloroethylene; OR 1.9 (95% CI 1.1–3.3); bone sarcoma with job as a carpenter/joiner; 
OR 4.3 (95% CI 1.7–10.5); and uveal melanoma with job as a welder/sheet metal worker; OR 1.95 (95% CI 1.08–3.52); 
and cook; OR 2.4 (95% CI 1.4–4.3). A confirmatory study of printers enhanced suspicion of 1,2-dichloropropane as a risk 
for biliary tract cancer. Results contributed to evidence for classification of welding and 1,2-dichloropronane as human car-
cinogens. However, despite efforts across nine countries, for some cancer sites only about 100 cases were interviewed. The 
Rare Cancer Study illustrated both the strengths and limitations of explorative studies for identification of etiological leads.
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Introduction
Rare cancers together constitute a considerable part of the 
cancer burden. In Europe, a rare cancer was defined as a can-
cer with an incidence of less than six per 100,000. This led 
to identification of 198 disease entities, together constituting 
24% of cancers diagnosed in the European Union [1]. Occu-
pational exposures are known risk factors for several rare 
cancers; examples are asbestos and pleural mesothelioma, 
and benzene and acute myeloid leukemia [2].
The potentially occupational origin of rare cancers has 
in most cases been suggested by alert clinicians. Exposure 
to wood dust as a risk factor for nasal adenocarcinomas was 
based on a cluster in furniture-makers in Buckinghamshire, 
United Kingdom [3]. A causal link between vinyl chloride 
and liver angiosarcoma was suggested by two company phy-
sicians observing four cases among workers in the polym-
erization section of a plant in Kentucky, United States [4]. 
Recently, a cluster of cholangiocarcinomas was observed in 
a small offset color-proof printing facility in Osaka, Japan, 
where workers had been exposed to 1,2-dichloropropane and 
dichloromethane [5].
On this background, one might hypothesize that a sys-
tematic search for associations between occupational expo-
sures and rare cancers would reveal new etiological leads. To 
obtain sufficient numbers, patients for such a study should be 
recruited from a large population. We undertook a European 
multi-center case–control study on risk factors for seven rare 
cancers. Incident cases and controls were recruited from 
nine European countries with personal interviews of 4000 
participants. Here we report on selected key findings and in 
light of our experiences discuss strengths and limitations of 
this study approach. * Elsebeth Lynge  elsebeth@sund.ku.dk
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Material and methods
The Rare Cancer Study aimed to serve both as a confirma-
tory study of specified hypotheses, and as an explorative 
study. The design was described previously [6]. In short, 
incident cases aged 35–69 years diagnosed 1995–1997 with 
cancers of the small intestine, bone sarcoma, uveal mela-
noma, mycosis fungoides, thymus, and male biliary tract 
and male breast were recruited. The lower age limit was set 
to allow for some time for accumulation of occupational 
exposures prior to age of diagnosis, and the upper age limit 
was set to avoid comorbidities that would incapacitate par-
ticipation. The seven cancer sites were chosen based on a 
literature review [7], which indicated that occupational risk 
factors could be involved in the etiology of these diseases. 
Population-based in Denmark and Latvia, in ten areas in 
France, five in Germany, three in Italy, and four in Sweden; 
hospital-based in three places in Spain, two in Portugal, and 
at one eye-hospital in United Kingdom, Fig. 1. Cases were 
reviewed by an expert pathologist. Sex and age-matched 
population-controls four times the most frequent cancer 
were selected from Denmark, France, Germany, Italy, and 
Sweden, and colon cancer controls from Denmark, and from 
Latvia, Spain, and Portugal where population-controls could 
not be selected.
We aimed for interviewing all identified cases and 
selected controls. To ensure a high response rate, cases 
were interviewed as soon as possible after the diagno-
sis. If a case had died or was unable to participate, we 
aimed for interviewing a next-of-kin. Controls were inter-
viewed in batches throughout the data collection period. 
The pathology review was undertaken in parallel with the 
interviews, and in the analysis we included only inter-
viewed cases for whom the diagnosis was considered to be 
definite or possible. The core questionnaire covered demo-
graphic variables, eye color, medical and x-ray history, use 
of drugs, tobacco and alcohol, and occupational exposures 
as organic solvents, pesticides, and electromagnetic fields. 
A complete history was obtained of all jobs lasting at least 
six months including data on working hours, materials 
handled, and chemical exposures. In addition, using the 
method by Siemiatychi [8] we used 27 job-specific supple-
mentary questionnaires providing a comprehensive picture 
of the exposures in given job (ref). Questionnaires were 
translated into the languages of the respective countries. 
Jobs were coded using the International Classification of 
Occupations from 1968 [9], and the European Classifica-
tion of Industries from 1993 [10].
Associations between occupational exposure and cancer 
were assessed with unconditional logistic regression con-
trolled for sex, age, country, and known confounders, and 
reported as odds ratios (OR) with 95% confidence intervals 
(CI). Selected known associations with medical conditions 
were studied to check data validity, before associations with 
occupational exposures were explored. The study was under-
taken in accordance with Ethical Committee requirements 
in each country.
Results
In total, 1457 patients were recruited, with diagnosis 
assessed as definite/possible for 1252, and 1053 were inter-
viewed, almost 90% in-person, Table 1.
Use of colon cancer controls
In Denmark, both 320 population and 254 colon cancer con-
trols were recruited. The groups were similar in education, 
medical history and smoking, but colon cancer controls had 
higher alcohol intake, less frequent work as a farmer, and 
less exposure to pesticides than population controls [11]. 
These differences affected some findings.
The association between sunlight exposure and uveal 
melanoma was OR 1.91 (95% CI 1.22–2.98) with colon can-
cer controls; but only OR 1.24 (95% CI 0.88–1.74) with pop-
ulation controls; reflecting that farmers had outdoor work 
and low risk of colon cancer [12]. With both population 
and colon cancer controls exposure to pesticides showed an 
excess risk with bone sarcoma; OR 2.33 (95% CI 1.31–4.13), 
that decreased with population controls only; OR 1.63 (95% 
CI 0.77–3.45) [13].
Fig. 1  Geographical regions covered by the European multi-center 
case–control study on rare cancers of unknown etiology
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Biliary tract carcinoma in men
Biliary tract carcinoma was studied including 153 cases 
and 1421 population controls. A history of gallstones is 
a known risk factor, and this was confirmed; OR 4.68 
(95% CI 2.80–7.84) [14]. Questionnaire data on chemi-
cals were used to construct a cumulative exposure index 
taking probability, intensity and duration in each job into 
account. In the analysis, the exposed participants were 
categorized in tertiles; low, medium, high, of the joint 
distribution of cases and controls [15]. As an example, 
6%; 12%, 19% and 63% of biliary tract carcinoma cases 
were categorized as low, medium, high and unexposed, 
respectively, to endocrine-disrupting compounds. Expo-
sure to endocrine-disrupting compounds as a risk factor 
for male biliary tract carcinoma was studied, because the 
preponderance of this disease in women is assumed related 
to female sex hormones. The data showed an OR of 1.4 
(95% CI 0.9–2.0) based on all data, and of 1.7 (95% CI 
1.1–2.8) based on job-specific questionnaires, Table 2, 
with no dose–response relationship [15].
For the subgroup of endocrine disrupting compounds 
including oils with polychlorinated biphenyls (PCB) the OR 
was 2.8 (95% CI 1.3–5.9) for all data, and OR 3.2 (95% CI 
1.4–7.4) for job-specific questionnaires; no dose–response 
relationship. A possible causal association for PCB was sup-
ported by an OR of 2.3 (95% CI 1.2–4.5) for men employed 
in electrical work, as 70% of electrical workers were classi-
fied as exposed to endocrine-disrupting compounds, includ-
ing PCB [15]. No association was found with exposure to 
pesticides in general, and power was insufficient to distin-
guish between types [16].
Male breast cancer
The study included 104 cases and 1901 population/colon 
cancer controls showing the known association with gyne-
comastia; OR 23.42 (95% CI 4.65–117.97) [17]. Excess 
risks were indicated in health care and social work; OR 
2.3 (95% CI 1.1–5.1); forestry and logging; OR 2.4 (95% 
CI 1.0–5.6); wood preparation and paper makers; OR 2.4 
(95% CI 0.9–6.5); motor vehicle mechanics; OR 2.1 (95% CI 
1.0–4.4); painters; OR 2.3 (95% CI 1.0–5.2); and for alkyl-
phenolic compounds used as detergents in many industries; 
OR 3.3 (95% CI 1.1–9.9).
Exposure to organic solvents was assessed using a cumu-
lative exposure score constructed from the job history com-
bined with a French Job Exposure Matrix (JEM). Exposure 
probability, frequency, intensity and duration in each job 
were taken into account. In the analysis, exposed work-
ers were dichotomized into low and high according to the 
median score among the exposed controls [18]. For trichlo-
roethylene this resulted in 16% of cases being categorized as 
low exposed; 28% as high exposed; and 56% as unexposed. 
The risk of male breast cancer was increased for trichloro-
ethylene; OR 1.4 (95% CI 0.7–2.5) for low, and OR 1.9 (95% 
CI 1.1–3.3) for high score [18]. Results by occupation and 
JEM supported each other, as motor vehicle mechanics and 
painters were exposed to trichloroethylene.
Table 1  European rare cancer 
study. number of identified and 
interviewed cases and controls
NR Not relevant
a Includes 7 cases of unknown site; bmay indicate some incomplete identification of eligible controls; cnum-
bers from papers where the two subgroups were reported separately; ddue to missing values on some vari-
ables, the actual number of cases and controls included in a given analysis could be lower than the numbers 
interviewed. The numbers might also be slightly higher, reflecting for instance extra case recruitment of 
uveal melanoma cases in Germany





Uveal melanoma 359 317 289 81%
Male biliary tract 295 258 186 63%
Small intestine 251 216 171 68%
Adenocarcinoma 70c
Carcinoid 84c
Bone 138 116 105 76%
Thymus 137 113 101 74%
Mycosis fungoides 147 115 101 69%
Male breast 123 117 100 81%
Total 1457a 1252 1053 72%
Population control 3374 NR 2062 61%
Colon cancer control 1284b NR 1084 86%b
 E. Lynge et al.
1 3
Small‑bowel cancer
The association between Crohn’s Disease and small-bowel 
adenocarcinoma was confirmed; OR 53.6 (95% CI 6.0–477) 
[19]. Including 79 cases and 2649 population/colon cancer 
controls; for men increased risks were found for manufac-
ture of motor vehicles; OR 3.9 (95% CI 1.3–11.9); and for 
building caretaker; OR 5.7 (95% CI 1.8–18.3). For women 
increased risks were found for mixed farming; OR 3.2 (95% 
CI 1.3–8.3); manufacture of work wear and clothes; OR 3.5 
(95% CI 1.5–8.3); restaurants; OR 2.8 (95% CI 1.1–7.6); dry 
cleaner/launderer; OR 3.8 (95% CI 1.2–12.6); and general 
farm laborer; OR 4.6 (95% CI 1.8–12.0). Based on small 
numbers, risk tended to increase with duration in dry clean-
ing. Giving the deficit risk of colon cancer in farmers, and 
therefore the low number of farmers among colon cancer 
Table 2  Selected excess risks of occupational exposures for rare cancers observed in the European Rare Cancer Study
OR: odds ratio; CI: confidence interval; P: population control; C: colon cancer control; PCB: polychlorinated biphenyls; NOS: not otherwise 
specified
a Originally reported ORs with one or two digits, respectively, have been used
References Cancer site Type of con-trols Number of exposed Number of unex-
posed
ORa 95% CI
Cases Con-trols Cases Con-trols
[15] Male biliary tract carcinoma
All endocrine disrupting compounds P 41 477 37 716 1.7 1.1–2.8
Oils with PCB P 8 51 115 1820 3.2 1.4–7.4
[17] Male breast cancer
Health care and social work P 8 93 96 1808 2.3 1.1–5.1
Forestry and logging P 7 39 97 1862 2.4 1.0–5.6
Wood preparation and paper makers P 5 26 99 1875 2.4 0.9–6.5
Motor vehicle mechanics P 9 74 95 1827 2.1 1.0–4.4
Painters P 7 54 97 1847 2.3 1.0–5.2
Alkylphenolic compounds, high P 7 26 97 1875 3.3 1.1–9.9
[18] Trichloroethylene, high P + C 29 307 75 1594 1.9 1.1–3.3
[20] Small intestine adenocarcinoma
Men: Manufacture of motor vehicles P + C 4 57 40 1755 3.9 1.3–11.9
Men: Building caretaker P + C 4 28 40 1784 5.7 1.8–18.3
Women: Mixed farming P + C 7 42 28 795 3.2 1.3–8.3
Women: Manufacture of work wear and clothes P + C 8 68 27 769 3.5 1.5–8.3
Women: Restaurant P + C 6 46 29 791 2.8 1.1–7.6
Women: Dry cleaner/launderer P + C 4 31 31 806 3.8 1.2–12.6
Women: General farm laborer P + C 7 35 28 802 4.6 1.8–12.0
[21] Small intestine carcinoid
Men: Manufacture of bodies for motor vehicles P 3 11 48 1436 5.1 1.2–22.1
Men: Structural metal preparer/erector P 3 46 48 1401 4.3 1.2–15.9
Men: Other construction workers P 5 76 46 1371 3.1 1.1–8.6
Women: Wholesale, food and beverages P 3 13 30 610 8.2 1.9–34.9
[13] Bone sarcoma
Blacksmith, toolmaker, machine-tool operator P + C 11 199 85 2433 2.14 1.08–4.26
Bricklayer, carpenter, other construction P + C 14 215 82 2417 2.93 1.55–5.53
Of whom: carpenter, joiner, parquetry P + C 6 61 90 2571 4.25 1.71–10.5
Manufacture of wood, wood and cork products, 
straw and plaiting industry
P + C 9 88 87 2544 3.58 1.70–7.56
[12] Uveal melanoma
Cook P 18 62 274 2000 2.40 1.35–4.28
Welders and sheet metal workers P 16 86 276 1976 1.95 1.08–3.52
Service workers NOS P 66 395 226 1667 1.43 1.02–2.00
Launderers, dry-cleaners and pressers P 10 23 282 2039 3.14 1.44–6.86
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controls, the excess risks for mixed farming and general farm 
laborer should be considered with reservation [20].
A search for associations with small-bowel carcinoid for 
men and women together included 84 cases and 2070 popu-
lation controls with excess risks for women in wholesale, 
food and beverages; OR 8.2 (95% CI 1.9–34.9); and for men 
in manufacture of bodies for motor vehicles; OR 5.1 (95% 
CI 1.2–22.1); structural metal preparer/erector; OR 4.3 (95% 
CI 1.2–15.9); and other construction workers; OR 3.1 (95% 
CI 1.1–8.6) [21].
Bone sarcoma
The study included 96 bone sarcoma cases and 2632 popula-
tion/colon cancer controls [13] with excess risks for black-
smith, toolmaker, machine-tool operator, OR 2.14 (95% 
CI 1.08–4.26); bricklayer, carpenter, other construction 
worker; OR 2.93 (95% CI 1.55–5.53); and for the subgroup 
of carpenter, joiner, parquetry worker; OR 4.25 (95% CI 
1.71–10.5), and for manufacture of wood, wood and cork 
products, straw and plaiting industry; OR 3.58 (95% CI 
1.70–7.56). No evidence for association with duration of 
employment. In total, 18 cases reported work with pesti-
cides; OR 1.63 (95% CI 0.77–3.45); with indication of a 
dose–response pattern, and of a lower risk in persons using 
protective equipment; OR 1.36 (95% CI 0.38–4.84).
Uveal melanoma
Persons with light skin or blue/gray eyes have increased 
risk of uveal melanoma; corroborated in the French part 
of the study with OR 2.3 (95% 1.1–4.7) and OR 3.0 (95% 
CI 1.4–6.3), respectively [22]. Associations previously 
reported in the literature between occupation and uveal 
melanoma were confirmed for cooks; OR 2.40 (95% CI 
1.35–4.28); welders and sheet metal workers; OR 1.95 (95% 
CI 1.08–3.52); and service workers not otherwise specified; 
OR 1.43 (95% CI 1.02–2.00) [12]. In addition, an excess risk 
was found for launderers, dry-cleaners and pressers; OR 3.14 
(95% CI 1.44–6.86). The International Agency for Research 
on Cancer (IARC) classified welding as a group 1 carcino-
gen based on the excess risk of ocular melanoma reported 
in, amongst others, the Rare Cancer Study [23].
The Rare Cancer data were included in a meta-analysis 
identifying both welding; OR 2.05 (95% CI 1.20–3.51); 
and occupational cooking; OR 1.81 (95% CI 1.31–2.46) as 
risk factors, while the increase was marginal only for occu-
pational sunlight exposure; OR 1.37 (95% CI 0.96–1.96) 
[24]. So, while ultraviolet exposure from sunlight is the 
most important risk factor for skin melanoma this is not 
the case for uveal melanoma. As stated by Logan et al. [25] 
this is consistent with the properties of the adult crystal-
line lens and cornea to filter out wavelengths below 400 nm. 
However, short wave light at 400–500 nm, blue light, can 
reach the posterior uveal tract. Logan et al. noted that arc 
welding produces short-wave light. It can be added that blue 
light is emitted also by gas burners often used for profes-
sional cooking.
Thymoma
Due to their rarity and heterogeneous histology, hardly any-
thing is known about risks for thymoma. The Rare Cancer 
Study included 103 histologically confirmed cases showing 
a dose–response relationship for tobacco smoking, OR 2.1 
(95% CI 1.1–3.9) for > 41 pack-years; and no overall asso-
ciation with alcohol intake, but OR 2.4 (95% CI 1.1–5.4) 
for > 25 g/day of spirits [26].
Rare Cancer data in meta‑analysis
At the time of the Rare Cancer Study, a 7% increase in breast 
cancer risk in women per increment of 10 g alcohol/day had 
been demonstrated [27], but data for men were mixed. Alco-
hol consumption is high in countries included in the Rare 
Cancer Study, and the risk of male breast cancer increased 
with alcohol consumption, being more than fivefold for 
9 + drinks/day compared with < 1.5 drinks/day; OR 5.62 
(95% 1.54–20.52), [28], Table 3.
The Rare Cancer data were included in a meta-analysis 
of 14 studies where no association was found between alco-
hol intake and male breast cancer [29], Table 3. The pooled 
estimate for an intake of 9 + drinks/day compared with non-
drinkers was OR 1.08 (95% CI 0.74–1.58). The difference 
between patterns in the Rare Cancer Study and in the meta-
analysis was surprising, but most studies in the meta-anal-
ysis reported alcohol consumption during the last year, and 
misclassification may occur if former drinkers are then clas-
sified as non-drinkers. The consistency of the dose–response 
pattern in the Rare Cancer data makes it difficult to discard 
the result as a random finding.
Testing of new findings
The cluster of cholangiocarcinoma cases, both intra-and 
extrahepatic, from a printing company in Japan [5], was 
followed up in the Nordic Occupational Cancer Study 
(NOCCA) [30]. Male workers in printing and related indus-
tries had a standardized incidence ratio (SIR) of 2.34 (95% 
CI 1.45–3.57) for intrahepatic cholangiocarcinoma; and 
female workers a SIR of 1.95 (95% CI 0.84–3.85), while 
no association was found for extrahepatic cholangiocarci-
noma, ampulla of Vater, and gall bladder. In the Rare Cancer 
dataset, including gallbladder and extrahepatic cholangio-
carcinoma, printing workers had an OR of 2.42 (95% CI 
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0.81–7.24); being OR 5.78 (95% CI 1.43–23.29) for type-
setters [31].
From the majority of Japanese cases both detailed clinical 
findings [32], and pre-disease levels of liver enzymes meas-
ured in blood samples collected at annual health examina-
tions [33], supported a causal association between exposure 
to 1,2-dichloropropane and cholangiocarcinoma. In 2014, 
IARC classified 1,2-dichloropropane as carcinogenic to 
humans (Group 1) based on sufficient evidence in humans 
that exposure to 1,2-dichloropropane causes cholangiocar-
cinoma. Dichloromethane was classified as probably carci-
nogenic to humans (Group 2A) [34].
Discussion
The Rare Cancer Study showed that well established medi-
cal risk factors for the studied diseases could be reproduced, 
supporting a high validity of the collected data. The study 
illustrated also how use of cancer controls could lead to spu-
rious findings when the control disease itself was associated 
with the studied risk factor, as for colon cancer and outdoor 
work. Results from the Rare Cancer Study provided evi-
dence for classification of welding and 1,2-dichloropropane 
as carcinogenic to humans. The experiences from the Rare 
Cancer Study did, however, also illustrate some of the limi-
tations with this study approach.
Analysis by occupation
Despite major efforts in several countries with identifica-
tion of 1457 patients, only 1053 of these patients had both 
the diagnosis confirmed at the pathology review and com-
pleted the interview. This meant that only about 100 cases 
per cancer site could be included in the analysis. Broad 
occupational categories were therefore used in the analysis, 
i.e. “wholesale, food and beverages”, and with the expected 
heterogeneous working tasks, a possible association between 
a given exposure and a disease would be diluted, with only 
very strong associations remaining visible. This may explain 
why the observed ORs rarely exceeded 2–3 with the lower 
confidence limit close to one.
To overcome the heterogeneity, the analysis could pro-
ceed from broad to specific groups. An example was an OR 
of 2.93 (95% CI 1.55–5.53) for bone sarcomas in “brick-
layer, carpenter, other construction worker”, where the 
excess derived from “carpenter, joiner, parquetry worker”; 
OR 4.25 (95% CI 1.71–10.5). The possibility of a causal 
association was strengthened by an increased risk in manu-
facture of wood, wood and cork products, straw and plaiting 
industry; OR 3.58 (95% CI 1.70–7.56). A next logical step 
would have been to collect exposure and clinical data for 
the carpenters with bone sarcomas, but the group included 
only six patients, and an attempt to collect detailed data from 
several countries could easily fail for confidentiality and/or 
practical reasons.
Analysis by exposure
Analysis by exposure is a way to get around problems with 
analysis by occupation. In the study of male biliary tract 
cancer, an index of exposure to specific chemicals was con-
structed. The questionnaire job task data were, however, not 
detailed enough to assess probability, intensity, and dura-
tion of exposure, and approximations were needed. It is on 
this basis not possible to know whether the modest OR of 
1.7 (95% CI 1.1–2.8) for exposure to endocrine-disrupting 
compounds reflected a true value or a deflated value due to 
lack of sensitivity [15].
Table 3  Association between 
alcohol consumption (g/day) 
and male breast cancer
EU: European Union; NCI: National Cancer Institute, United States; g/d: gram per day; OR: odds ratio; CI: 
confidence interval





All studies Case–control 
studies
Cohort studies
OR 95% CI OR 95% CI OR 95% CI OR 95% CI
0–15 1 0 1 1 1
 > 0- < 5.93 0.94 0.76–1.16 0.95 0.71–1.27 0.93 0.68–1.27
 > 15–30 0.87 0.30–2.47  > 5.73- < 21.65 0.91 0.74–1.13 0.94 0.70–1.25 0.89 0.65–1.21
 > 21.65 1.09 0.88–1.34 1.02 0.77–1.36 1.17 0.85–1.60
 > 30–45 1.37 0.46–4.08
 > 45–60 2.28 0.73–7.11  > 45 1.21 0.97–1.53 1.18 0.89–1.56 1.28 0.87–1.90
 > 60–75 4.45 1.12–17.66  > 60 1.36 1.04–1.77 1.40 1.02–1.92 1.27 0.79–2.05
 > 75–90 4.68 1.07–20.55
 > 90 5.62 1.54–20.52  > 90 1.08 0.74–1.58 1.08 0.68–1.72 1.07 0.55–2.10
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A French JEM was used in the male breast cancer study 
to aggregate persons from occupations exposed to organic 
solvents; indicating an association with trichloroethylene; 
high exposure OR 1.9 (95% CI 1.1–3.3) [18]. Again, lack of 
details in the questionnaires might limit correct allocation, 
as study subjects had worked in eight countries over a period 
of three to four decades. NOCCA-data on male breast cancer 
were combined with a JEM for Nordic countries, showing 
for trichloroethylene an OR of 1.55 (95% CI 0.64–3.76) [35]. 
These two explorative studies indicate that the association 
between exposure to trichloroethylene and male breast can-
cer deserves further scrutiny. The NOCCA-data showed a 
reduced risk of male breast cancer for men with physical 
workloads; OR 0.78 (95% CI 0.67–0.91) [35]. This was not 
confirmed in the Rare Cancer Study with an OR of 0.9 (95% 
CI 0.6–1.4) for agriculture, and OR 2.4 (95% CI 1.0–5.6) for 
forestry/logging [17]; both physically demanding industries.
Reflections
It was an underlying assumption of the Rare Cancer Study 
that rare cancers do not occur at random but result from 
rare exposures and/or rare susceptibility to exposures, and 
that these risks could be identified in a systematic search for 
associations in a large dataset.
The study demonstrated, however, that the approach had 
build-in limitations. For each rare cancer site, systematic 
tabulation across occupations revealed some increased ORs, 
but mostly in the order of 2–3. These ORs may represent 
etiological associations buried in noise, or they may simply 
reflect random variation in tabulation of many associations. 
There is no way to solve this question within the dataset 
itself. The lack of sensitivity of the Rare Cancer Study for 
detection of signals is a characteristic shared with other 
explorative studies. An example is the NOCCA-study, where 
Nordic census data were linked individually with cancer data 
for 15 million persons [36], and where the largest diver-
gences between occupations were for cancers associated 
with tobacco and alcohol.
It is characteristic for reports where alert clinicians pro-
vided hints on occupational risks for rare cancers that they 
had very detailed data on the patients; both on exposures 
and histology, and sometimes even on pre-diagnostic bio-
markers. In comparison, data in explorative studies are very 
limited. The most constructive use of explorative studies in 
their present form is therefore for identification of consist-
ent findings across studies, as for uveal melanoma in weld-
ers and cooks, and for targeted studies of already suspected 
associations, as for cholangiocarcinoma in printers. It is 
therefore important to document and store the data, and to 
make them easily available for researchers.
As stated in the preamble to the IARC Monographs 
on the identification of carcinogenic hazards to humans 
[37], evidence for a causal association in human studies is 
strengthened by consistent findings. Outcomes from explora-
tive studies may play an important role here, and as illus-
trated above data from the Rare Cancer Study have proved 
valuable in this context. Explorative studies may also form 
part of surveillance systems for occupational safety and 
health [38]. The usefulness of explorative studies in iden-
tifying new possible forms of work risks to better protect 
workers could be further enhanced, if risks revealed in the 
statistical analysis could be followed up by confirmatory 
studies of the relevant sub-groups with individual data on 
diagnoses, exposures, and possible confounders. However, 
the possibility for such targeted enrichment of explorative 
studies is limited by data protection rules.
The present disease pattern reflects the history of our 
life, and as the working conditions have changed over time 
one could question the relevance of results from explorative 
studies for future protection of workers. Some aspects of 
working environments are, however, relatively stable over 
time, and there is no doubt that the identification of carci-
nogenic compounds and work processes has in itself been a 
driver for changes in working conditions [39].
In conclusion, the Rare Cancer Study proved it possible to 
collect valid data with interviews conducted in several lan-
guages. However, despite efforts across Europe only about 
100 cases per cancer site could be identified, confirmed, 
and interviewed within the study period. The sensitivity of 
explorative studies in the search for etiological leads is lim-
ited by use of broad occupational groups and lack of access 
to individual, detailed exposure and clinical data. The Rare 
Cancer data set is a valuable source for comparisons of find-
ings across explorative studies and for targeted confirmatory 
studies.
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